Nevis Capital LLP
Nevis Capital invests in small and medium sized businesses across the UK. Whilst our heritage is in industrial and business services, we have an appetite to back profitable established businesses across most sectors. We are different to other funders as our team has a proven track record of successfully growing their own businesses. This means that we understand the challenges of growth first-hand, and as we only invest our own money, we are able to take a long term view with no set time frames or pressure to exit.
<br />
<br />
We are flexible in our approach and will tailor a deal to meet the vendor’s objectives. Typically, we will buy businesses outright and share some equity with the management team. We will also provide a partial exit to vendors who want to stay involved, back management teams to complete a buy-out or provide growth funding.
New Age Capital
New Age Capital is a seed stage venture capital firm and lifestyle company investing in tech startups founded by blacks and latinos. Their mission is to work with the best Black and Latino entrepreneurs solving "real world" problems.
<br />
New Block Capital
NewBlock Capital is reshaping the way we perceive finance. Our balanced team of managers, traders, and technology experts are catalyzing the next financial revolution with proven short and longterm investment strategies. This hedge fund was built from the ground up to focus on blockchain technology, digital currencies, and innovative projects. We differentiate by offering an investment strategy that symbiotically caters to our clients and the greater blockchain ecosystem. Our team’s mission is to responsibly grow wealth for our clients.
New Crop Capital
New Crop Capital is an evergreen fund managed by Unovis Partners, a global investment firm focused on companies developing replacements to animal protein products. Unovis’ mission is to transform the global food system by investing in solutions that facilitate sustained behavioral change and eliminate the production and consumption of animal protein products. Post investment, Unovis supports founders by sharing their culinary knowledge, understanding of consumer habits, experience in food manufacturing, and network of industry experts to de-risk investments and build strong, resilient brands.
<br />
New Enterprise Associates Inc
New Enterprise Associates, Inc., doing business as NEA, operates as a venture capital firm. The Company invests in biopharmaceuticals, medical devices, technology, and healthcare sectors. NEA serves customers in the United States.
New Ground Ventures
New Ground Ventures is an investment platform established to fund and support breakthrough companies. NGV makes seed to later stage investments in companies ranging from pre-revenue to as much as $10 million in annual sales. The fund invests opportunistically in multiple sectors, with a focus on Technology, Food, Health and Wellness, and Education.
<br />
New Horizon Capital
New Horizon Capital is a top-tier private equity fund focusing on investing in china. It was incorporated in Cayman Islands in May 2005 with two limited partners: Tamasek Holdings Private Limited and SBI Holdings Inc. They currently manage over approximately $2.5 billion RMB and USD funds. Their LPs include more than 20 internationally renowned institutions
<br />
<br />
The Fund is managed by a group of highly professional and experienced staff who have very strong business sense to identify and capture various investment opportunities. The firm invests in companies in consumer & retail, alternative energy, pharmaceutical & healthcare and advanced manufacturing sectors. It makes investment either through purchase of non-tradable stocks of domestic listed company or equity interest in private company at expansion stage.
New Horizon Capital Co. Ltd.
New Horizon Capital (NHC) is a Japanese leading PE fund targeting mid- to small-cap buyout deals
<br />
such as Carve-outs, Business Successions, Growth Enhancement and Turnaround.
<br />
Bearing our fiduciary duties to investors in mind, we are independent of any specific financial institution to avoid conflict of interest, and keen to comply with regulations.
New Industry
The New Industry Ventures fund is being established to stimulate the promotion of high-tech products on the Russian market and to support innovative companies and start-ups crucial to the development of Russia’s oil and gas, fuel and energy and wider industries. The fund’s activities will prioritise developing technologies for the exploration, production, processing, transportation, distribution and utilisation of hydrocarbons, as well as energy transmission and storage, the implementation of innovative solutions for industrial infrastructure construction, management of major projects, and so on. Its investment focus will also include resource-management and energy-saving technologies, as well as digital products including Industry 4.0 technologies.
New Industry Ventures has an initial funding target of RUB4 billion, which may be increased in the future, at the agreement of the parties. Its initial period of activity has been confirmed at seven years, again subject to potential extension by agreement of the parties. The fund will be managed by a specially created investment partnership management company, with an independent team of professional market players experienced in venture capital investments and specialising in technology.
New Leaf Venture Partners
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.